Search research articles
Contact Us
Filters
Showing results (531-540 of 560) with videos related to
Page
of 56
Sort By:
BMJ Open
|
April 30, 2021
Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)
Mahrukh Imran, Linda Kwakkenbos, Stephen J McCall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Nature Medicine
|
May 15, 2020
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C Yuen, Li-Fen Liu, Vinita Gupta, et al.
Nature Medicine
|
February 6, 2021
Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C Yuen, Li-Fen Liu, Vinita Gupta, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
Eric D Hsi, Roxanne Steinle, Balaji Balasa, et al.
United European Gastroenterology Journal
|
December 24, 2025
Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project
Irina Midenfjord, Mahrukh Khadija, Elias Sundelin, et al.
The Journal of Clinical Investigation
|
August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy
Leisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Annals of Surgical Oncology
|
September 12, 2020
Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia
Michael J Carr, James Sun, Hidde M Kroon, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer
John Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Page
of 56
Search research articles
Search
Showing results (531-540 of 560) with videos related to
Sort By:
Page
of 56
BMJ Open
|
April 30, 2021
Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)
Mahrukh Imran, Linda Kwakkenbos, Stephen J McCall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Nature Medicine
|
May 15, 2020
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C Yuen, Li-Fen Liu, Vinita Gupta, et al.
Nature Medicine
|
February 6, 2021
Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C Yuen, Li-Fen Liu, Vinita Gupta, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
Eric D Hsi, Roxanne Steinle, Balaji Balasa, et al.
United European Gastroenterology Journal
|
December 24, 2025
Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project
Irina Midenfjord, Mahrukh Khadija, Elias Sundelin, et al.
The Journal of Clinical Investigation
|
August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy
Leisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Annals of Surgical Oncology
|
September 12, 2020
Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia
Michael J Carr, James Sun, Hidde M Kroon, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer
John Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Page
of 56